急性循環不全

出版社： 中山書店
著者：
発行日： 2019-05-30
分野： 臨床医学：一般  >  救命/救急
ISBN： 9784521743356
電子書籍版： 2019-05-30 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

11,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

11,000 円(税込)

購入する

商品紹介

生命に危機の迫る急性循環不全に対しては，その病態を正確に判断し，適切に対処しなければならない．本書では，管理に不可欠な各種モニタリング法の目的と限界，循環不全を引き起こすショックと重症心疾患を取り上げて，それぞれの病態と治療について解説した．IABP，ECMO，補助人工心臓などの導入と管理のポイント，輸液療法や薬物療法などについても詳述．集中治療医，救急医必携の1冊．

目次

  • 1章　定義と診断
    2章　診断補助
    3章　症状・疾患における病態と治療
    4章　治療選択

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 定義と診断

P.8 掲載の参考文献
1) Marino PL. The ICU Book. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2007. 稲田英一, 監訳. ICUブック. 第3版. 東京 : メディカル・サイエンス・インターナショナル ; 2008. p.18-33.
 
2) 外須美夫. 呼吸・循環のダイナミズム-学生から臨床医まで呼吸・循環の体系的理解のために. 東京 : 真興交易医書出版部 ; 2001. p.110-34.
 
3) Cecconi M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014 ; 40 : 1795-815.
PubMed
4) Lima A. Circulatory shock and peripheral circulatory failure : A historical perspective. Neth J Crit Care 2014 ; 18 : 14-8.
 
5) 丸藤哲. ショックの診断と緊急処置. 相川直樹, 青木克憲, 編. クリティカルケアSIRS・ショック・MODS. 東京 : 医学書院 ; 2001. p.70-85.
 
6) Vincent JL, et al. Clinical review : Circulatory shock-an update : A tribute to Professor Max Harry Weil. Crit Care 2012 ; 16 : 239.
 
7) Ait-Oufella H, et al. Mottling score predicts survival in septic shock. Intensive Care Med 2011 ; 37 : 801-7.
PubMed
8) Lima A, et al. The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med 2009 ; 37 : 934-8.
PubMed
9) Cohn JN. Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 1967 ; 199 : 118-22.
PubMed
10) McGee S, et al. The rational clinical examination. Is this patient hypovolemic? JAMA 1999 ; 281 : 1022-9.
PubMed
11) Hernandez G, et al. Persistent sepsis-induced hypotension without hyperlactatemia : Is it really septic shock? J Crit Care 2011 ; 26 : 435. e9-14.
 
12) Wacharasint P, et al. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012 ; 38 : 4-10.
PubMed
13) Hendy A, Bubenek-Turconi SI. The Diagnosis and Hemodynamic Monitoring of Circulatory Shock : Current and Future Trends. J Crit Care Med 2016 ; 2 : 115-23.
 
P.20 掲載の参考文献
1) Simmons J, Ventetuolo CE. Cardiopulmonary monitoring of shock. Curr Opin Crit Care 2017 ; 23 : 223-31.
PubMed
2) Stead R, et al. Developmental conditioning of endothelium-derived hyperpolarizing factor-mediated vasorelaxation. J Hypertens 2016 ; 34 : 452-63.
PubMed
3) Ghimire K, et al. Nitric oxide : What's new to NO? Am J Physiol Cell Physiol 2017 ; 312 : C254-62.
 
4) Gheibi S, et al. Regulation of vascular tone homeostasis by NO and H2S : Implications in hypertension. Biochem Pharmacol 2018 ; 149 : 42-59.
PubMed
5) Nallamshetty S, et al. Hypoxia : A master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013 ; 64 : 20-30.
PubMed
6) Batisse-Lignier M, et al. Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies : Different Prognoses? : A Systematic Analytical Review. Medicine (Baltimore) 2015 ; 94 : e2198.
PubMed
7) Brodde OE, et al. Receptor systems in the non-failing human heart. Basic Res Cardiol 1992 ; 87 Suppl 1 : 1-14.
 
8) Maleckar MM, et al. Studying dyadic structure-function relationships : A review of current modeling approaches and new insights into Ca2+ (mis) handling. Clin Med Insights Cardiol 2017 ; 11 : 1179546817698602.
PubMed
9) Wang Y, et al. Mitochondrial regulation of cardiac aging. Biochim Biophys Acta Mol Basis Dis 2018 Dec 26. pii : S0925-4439 (18) 30494-0.
 
10) Suematsu Y, et al. Safety and feasibility of high dose administration of nicorandil before reperfusion therapy in acute myocardial infarction. Cardiovasc Interv Ther 2013 ; 28 : 352-61.
PubMed
11) Iwakura K, et al. Nicorandil treatment in patients with acute myocardial infarction : A meta-analysis. Circ J 2009 ; 73 : 925-31.
PubMed
12) Wang P, et al. Exchange proteins directly activated by cAMP (EPACs) : Emerging therapeutic targets. Bioorg Med Chem Lett 2017 ; 27 : 1633-9.
PubMed
P.29 掲載の参考文献
1) 救急振興財団企画調査課. 救急搬送における重症度・緊急度判断基準作成委員会報告書. 平成16年3月. http://www.fasd.or.jp/tyousa/hanso01.pdf
 
2) 日本救急医学会, 監修, 日本救急医学会 専門医認定委員会, 編. 救急診療指針. 改訂第4版. 東京 : へるす出版 ; 2011. p.74.
 
3) Hagiwara A, et al. Monitoring variations in stroke volume enables precise evaluation of fluid resuscitation in patients with septic shock on pressure support ventilation. Austin J Emergency & Crit Care Med 2015 ; 39 : 155-60.
 
4) Cannon JW. Hemorrhagic Shock. N Engl J Med 2018 ; 378 : 370-9.
PubMed
5) Wackers FJ, et al. Coronary artery disease in patients dying from cardiogenic shock or congestive heart failure in the setting of acute myocardial infarction. Br Heart J 1976 ; 38 : 906-10.
PubMed
6) 鍬方安行, ほか. 肺動脈楔入圧は敗血症患者の前負荷指標として適切か? 日救急医会誌 1998 ; 9 : 1-7.
 
7) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 心臓突然死の予知と予防法のガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010aizawa.h.pdf
 
8) Bayes de Luna A, et al. Ambulatory sudden cardiac death : Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989 ; 117 : 151-9.
PubMed
9) 日本外傷学会, 日本救急医学会, 監修. 日本外傷学会外傷初期診療ガイドライン改訂第4版編集委員会, 編. 改訂第4版 外傷初期診療ガイドラインJATEC. 東京 : へるす出版 ; 2012. p.76.
 
10) 日本集中治療医学会・日本救急医学会合同 日本版敗血症診療ガイドライン2016作成特別委員会. 日本版敗血症診療ガイドライン 2016. 日救急医会誌 2017 ; 28 : S1-S232. http://www.jaam.jp/html/info/2017/pdf/J-SSCG2016_honpen.pdf
 

2章 診断補助

P.36 掲載の参考文献
1) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 急性心不全治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_izumi_h.pdf
 
2) Perera P, et al. The RUSH Exam : Rapid Ultrasound in Shock in the Evaluation of the Critically Ill. Emerg Med Clin North Am 2010 ; 28 : 29-56.
 
3) Cecconi M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of European Society of Intensive Care Medicine. Intensive Care Med 2014 ; 40 : 1795-815.
PubMed
4) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 循環器超音波検査の適応と判読ガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010yoshida.h.pdf
 
5) Sandroni C, et al. Accuracy of plethysmographic indices as predictors of fluid responsiveness in mechanically ventilated adults : A systematic review and meta-analysis. Intensive Care Med 2012 ; 38 : 1429-37.
PubMed
6) Lee M, et al. The Swan-Ganz Catheter Remains a Critically Important Component of Monitoring in Cardiovascular Critical Care. Can J Cardiol 2017 ; 33 : 142-7.
PubMed
P.43 掲載の参考文献
1) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.asas.or.jp/jhfs/pdf/topics20180323.pdf
 
2) Pistolesi M, et al. The vascular pedicle of the heart and the vena azygos. Part II : Acquired heart disease. Radiology 1984 ; 152 : 9-17.
PubMed
3) Ely EW, et al. Radiologic determination of intravascular volume status using portable, digital chest radiography : A prospective investigation in 100 patients. Crit Care Med 2001 ; 29 : 1502-12.
PubMed
4) Ely EW, Haponik EF. Using the chest radiograph to determine intravascular volume status : The role of vascular pedicle width. Chest 2002 ; 121 : 942-50.
PubMed
5) Tocino IM, et al. Distribution of pneumothorax in the supine and semirecumbent critically ill adult. AJR Am J Roentgenol 1985 ; 144 : 901-5.
PubMed
P.51 掲載の参考文献
1) Vandenberk B, et al. Which QT Correction Formulae to Use for QT Monitoring? J Am Heart Assoc 2016 ; 5. pii : e003264. doi : 10.1161/JAHA.116.003264.
 
2) Anderson ST, et al. Panoramic display of the orderly sequenced 12-lead ECG. J Electrocardiol 1994 ; 27 : 347-52.
PubMed
3) Sgarbossa EB, et al. Twelve-lead electrocardiogram : The advantages of an orderly frontal lead display including lead -aVR. J Electrocardiol 2004 ; 37 (3) : 141-7.
PubMed
P.56 掲載の参考文献
1) Grocott MPW, et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 2009 ; 360 : 140-9.
 
2) He HW, Liu DW. Permissive hypoxemia/conservative oxygenation strategy : Dr. Jekyll or Mr. Hyde? J Thorac Dis 2016 ; 8 : 748-50.
PubMed
3) Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016 ; 315 : 801-10.
PubMed
4) Hogue CW, et al. Cardiopulmonary bypass management and neurologic outcomes : An evidence-based appraisal of current practices. Anesth Analg 2006 ; 103 : 21-37.
PubMed
P.65 掲載の参考文献
1) Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016 ; 37 : 2129-200.
 
2) Nohria A, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003 ; 41 : 1797-804.
PubMed
3) Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Fail 2005 ; 7 : 323-31.
PubMed
4) Nagueh SF, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography : An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016 ; 29 : 277-314.
PubMed
5) Geske JB, et al. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy : Correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 2007 ; 116 : 2702-8.
PubMed
6) Munagala VK, et al. Association of newer diastolic function parameters with age in healthy subjects : A population-based study. J Am Soc Echocardiogr 2003 ; 16 : 1049-56.
PubMed
7) Ommen SR, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures : A comparative simultaneous Doppler-catheterization study. Circulation 2000 ; 102 : 1788-94.
PubMed
8) Abhayaratna WP, et al. Left atrial size : Physiologic determinants and clinical applications. J Am Coll Cardiol 2006 ; 47 : 2357-63.
PubMed
P.72 掲載の参考文献
1) Ames JT, Federle MP. CT hypotension complex (shock bowel) is not always due to traumatic hypovolemic shock. AJR Am J Roentgenol 2009 ; 192 : W230-5.
 
2) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf
 
3) 日本循環器学会, ほか. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_ito_h.pdf
 
4) Leipsic J, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography : A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2014 ; 8 : 342-58.
 
5) Koyama Y, et al. Assessment of reperfused acute myocardial infarction with twophase contrast-enhanced helical CT : Prediction of left ventricular function and wall thickness. Radiology 2005 ; 235 : 804-11.
PubMed
P.81 掲載の参考文献
1) Gelzinis TA, et al. Cardiac catheterization laboratory : Diagnostic and therapeutic procedures in the adult patient. In : Kaplan JA, et al. Kaplan's Essentials of Cardiac Anesthesia for Cardiac Surgery. 2nd ed. Philadelphia : Elsevier ; 2018.
 
2) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). ST上昇型急性心筋梗塞の診療に関するガイドライン (2013年改訂版). p.1-86. http://www.j-circ.or.jp/guideline/pdf/JCS2013_kimura_h.pdf
 
3) Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018 ; 39 : 119-77.
 
4) 日本蘇生協議会, 監修. JRC蘇生ガイドライン 2015. 東京 : 医学書院 ; 2016.
 
5) Higuma T, et al. A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction : Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2015 ; 8 : 1166-76.
 
6) Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 ; 367 : 1287-96.
PubMed
7) O'Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction : Executive summary : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 ; 127 : 529-55.
 
8) Shiomi H, et al. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention : observational study. BMJ 2012 ; 344 : e3257.
PubMed
9) Thiele H, et al ; CULPRIT-SHOCK Investigators. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med 2017 ; 377 : 2419-32.
PubMed
10) Thygesen K, et al. Third universal definition of myocardial infarction. Circulation 2012 ; 126 : 2020-35.
PubMed
11) Kobayashi N, et al. Characteristics of patients with cardiac arrest caused by coronary vasospasm. Circ J 2013 ; 77 : 673-8.
PubMed
12) Tateishi K, et al. Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest : Diagnostic and therapeutic importance of vasospastic angina. Eur Heart J Acute Cardiovasc Care 2018 ; 7 : 405-13.
PubMed
13) 堀正二, 監修. 坂田泰史, ほか編. 循環器用語ハンドブック. 第3版. 大阪 : メディカルレビュー社 ; 2015.
 
14) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). p.1-131. http://www.asas.or.jp/jhfs/pdf/topics20180323.pdf
 
P.88 掲載の参考文献
1) Thygesen K, et al. Third universal definition of myocardial infarction. Circulation 2012 ; 126 : 2020-35.
PubMed
2) Reichlin T, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009 ; 361 : 858-67.
PubMed
3) Hamm CW, et al ; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 ; 32 : 2999-3054.
 
4) 佐藤幸人, ほか. 循環器疾患における血中BNP, NT-proBNP測定の意義. J Cardiol Jpn Ed 2008 ; 2 : 163-77.
 
5) Masson S, et al ; Val-HeFT Investigators. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure : The Valsartan Heart Failure (Val-HeFT) data. Clin Chem 2006 ; 52 : 1528-38.
 
6) Maisel AS, et al ; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 ; 347 : 161-7.
 
7) Januzzi JL Jr, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005 ; 95 : 948-54.
 
8) Januzzi JL, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure : An international pooled analysis of 1256 patients : The International Collaborative of NT-proBNP Study. Eur Heart J 2006 ; 27 : 330-7.
 
9) Januzzi JL Jr, et al. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol 2008 ; 101 : 29A-38A.
 
10) Suzuki T, et al ; IRAD-Bio Investigators. Diagnosis of acute aortic dissection by D-dimer : The International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009 ; 119 : 2702-7.
PubMed
11) Sato Y, et al. Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin. Int J Cardiol 2008 ; 126 : 171-6. Epub 2007 Dec 11.
 
12) Pang PS, et al. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes : An Exploratory Analysis From the RELAX-AHF Trial. JACC Heart Fail 2016 ; 4 : 591-9. doi : 10.1016/j.jchf.2016.02.009. Epub 2016 Mar 30.
 
13) Inazumi H, et al. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol 2016 ; 67 : 98-103. doi : 10.1016/j.jjcc.2015.04.014. Epub 2015 Jun 15.
 
14) Koyama S, et al. Early evolution and correlates of urine albumin excretion in patients presenting with acutely decompensated heart failure. Circ Heart Fail 2013 ; 6 : 227-32. doi : 10.1161/CIRCHEARTFAILURE.112.000152. Epub 2013 Feb 8.
 
15) Nakayama H, et al. Prognostic Value of Rising Serum Albumin During Hospitalization in Patients With Acute Heart Failure. Am J Cardiol 2016 ; 117 : 1305-9. doi : 10.1016/j.amjcard.2016.01.030. Epub 2016 Mar 5.
 
P.96 掲載の参考文献
1) Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013 ; 369 : 1726-34.
PubMed
2) 小竹良文. その他の心拍出量測定. Intensivist 2011 ; 3 : 229-43.
 
3) Rivers E, et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. N Engl J Med 2001 ; 345 : 1368-77.
PubMed
4) ProCESS Investigators, Yealy DM, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014 ; 370 : 1683-93.
PubMed
5) ARISE Investigators ; ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014 ; 371 : 1496-506.
 
6) Harvey S, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man) : A randomised controlled trial. Lancet 2005 ; 366 : 472-7.
 
7) Hollenberg SM. Hemodynamic monitoring. Chest 2013 ; 143 : 1480-8.
PubMed
8) Spahn DR, Chassot PG. CON : Fluid restriction for cardiac patients during major noncardiac surgery should be replaced by goal-directed intravascular fluid administration. Anesth Analg 2006 ; 102 : 344-6.
PubMed
9) Bentzer P, et al. Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? JAMA 2016 ; 316 : 1298-309.
PubMed
10) Marik PE. Fluid Responsiveness and the Six Guiding Principles of Fluid Resuscitation. Crit Care Med 2016 ; 44 : 1920-2.
PubMed
11) De Backer D, Vincent JL. Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Crit Care 2018 ; 22 : 43.
PubMed
12) Michard F, Teboul JL. Using heart-lung interactions to assess fluid responsiveness during mechanical ventilation. Crit Care 2000 ; 4 : 282-9.
PubMed
13) Biais M, et al. Case scenario : Respiratory variations in arterial pressure for guiding fluid management in mechanically ventilated patients. Anesthesiology 2012 ; 116 : 1354-61.
PubMed
14) Cannesson M, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness : A "gray zone" approach. Anesthesiology 2011 ; 115 : 231-41.
 
15) Biais M, et al. End-Expiratory Occlusion Test Predicts Fluid Responsiveness in Patients With Protective Ventilation in the Operating Room. Anesth Analg 2017 ; 125 : 1889-95.
PubMed
16) Biais M, et al. Mini-fluid Challenge of 100 ml of Crystalloid Predicts Fluid Responsiveness in the Operating Room. Anesthesiology 2017 ; 127 : 450-6.
PubMed

3章 症状・疾患における病態と治療

P.109 掲載の参考文献
1) Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart 2015 ; 101 : 1159-68.
PubMed
2) 日本外傷学会, 日本救急医学会, 監修. 外傷初期診療ガイドラインJATEC. 改訂第5版. 東京 : へるす出版 ; 2016. p.79, 94, 95.
 
3) van Belle A, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006 ; 295 : 172-9.
PubMed
4) Klok FA, et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008 ; 168 : 2131-6.
PubMed
5) Freund Y, et al. Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients : The PROPER Randomized Clinical Trial. JAMA 2018 ; 319 : 559-66.
 
6) Perera P, et al. The RUSH exam : Rapid Ultrasound in SHock in the evaluation of the critically ill. Emerg Med Clin North Am 2010 ; 28 : 29-56.
 
7) Yarmus L, Feller-Kopman D. Pneumothorax in the critically ill patient. Chest 2012 ; 141 : 1098-105.
PubMed
8) Volpicelli G, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012 ; 38 : 577-91.
PubMed
9) Sabbar S, Nilles EJ. Deep sulcus sign. N Engl J Med 2012 ; 366 : 552.
PubMed
10) Akhter M, et al. Ruling out Pulmonary Embolism in Patients with High Pretest Probability. West J Emerg Med 2018 ; 19 : 487-93.
 
11) 日本循環器学会, ほか. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_ito_h.pdf
 
12) Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014 ; 35 : 3033-69, 3069a-3069k.
 
13) Wan S, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism : A meta-analysis of the randomized controlled trials. Circulation 2004 ; 110 : 744-9.
PubMed
14) Fukuda I, et al. Improved Outcome of Surgical Pulmonary Embolectomy by Aggressive Intervention for Critically Ill Patients. Ann Thorac Surg 2011 ; 91 : 728-32.
PubMed
15) L'italien JA, et al. Critical cardiovascular skills and procedures in the emergency department. Emerg Med Clin North Am 2013 ; 31 : 151-206.
 
16) Ho AM, et al. Timing of tracheal intubation in traumatic cardiac tamponade : A word of caution. Resuscitation 2009 ; 80 : 272-4.
PubMed
17) MacDuff A, et al. Management of spontaneous pneumothorax : British Thoracic Society Pleural Disease Guideline. Thorax 2010 ; 65 : ii18-31.
PubMed
P.119 掲載の参考文献
1) Walker RH, ed, American Association of Blood Banks. Technical Manual. 10th ed. Arlington, VA : American Association of Blood Banks ; 1990. p.650.
 
2) Cropp GJ, et al. Changes in blood and plasma volumes during growth. J Pediatr 1971 ; 78 : 220-9.
PubMed
3) Nelson DP, et al. Systemic and intestinal limits of O2 extraction in the dog. J Appl Physiol 1987 ; 63 : 387-94.
PubMed
4) American College of Surgeons Committee on Trauma. Advanced Trauma Life Support (ATLS(R) Student Course Manual). 9th ed. Chicago, IL : American College of Surgeons ; 2013.
 
5) Mutschler M, et al. The ATLS(R) classification of hypovolemic shock : A well established teaching tool on the edge? Injury 2014 ; 45 Suppl 3 : S35-8.
 
6) Gutierrez G, et al. Clinical review : Hemorrhagic shock. Crit Care 2004 ; 8 : 373-81.
PubMed
7) 田熊清継, ほか. 内因性疾患による交通外傷の検討. 日救急医会誌 2006 ; 17 : 177-82.
 
8) Morrison JE, et al. Syncope-related trauma : Rationale and yield of diagnostic studies. J Trauma 1999 ; 46 : 707-10.
PubMed
9) Cordts PR, et al. Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations. Surg Gynecol Obstet 1992 ; 175 : 243-8.
PubMed
10) Brohi K, et al. Acute traumatic coagulopathy. J Trauma 2003 ; 54 : 1127-30.
PubMed
11) Gonzalez E, et al. Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy : A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays. Ann Surg 2016 ; 263 : 1051-9.
PubMed
12) Odom SR, et al. Lactate clearance as a predictor of mortality in trauma patients. J Trauma Acute Care Surg 2013 ; 74 : 999-1004.
PubMed
13) 日本外傷学会外傷初期診療ガイドライン改訂第4版編集委員会, 編. 改訂第4版 外傷初期診療ガイドラインJATEC(TM). 東京 : へるす出版 ; 2012.
 
14) Lingawi SS, Buckley AR. Focused abdominal US in patients with trauma. Radiology 2000 ; 217 : 426-9.
PubMed
15) McGahan JP, et al. Use of ultrasonography in the patient with acute abdominal trauma. J Ultrasound Med 1997 ; 16 : 653-62 ; quiz 663-4.
 
16) Miller MT, et al. Not so FAST. J Trauma 2003 ; 54 : 52-9 ; discussion 59-60.
 
17) Huber-Wagner S, et al. Effect of whole-body CT during trauma resuscitation on survival : A retrospective, multicentre study. Lancet 2009 ; 373 : 1455-61.
PubMed
18) Tillou A, et al. Is the use of pan-computed tomography for blunt trauma justified? A prospective evaluation. J Trauma 2009 ; 67 : 779-87.
PubMed
19) Pallin DJ, Saltzman JR. Is nasogastric tube lavage in patients with acute upper GI bleeding indicated or antiquated? Gastrointest Endosc 2011 ; 74 : 981-4.
PubMed
20) Kouanda AM, et al. Urgent colonoscopy in patients with lower GI bleeding : A systematic review and meta-analysis. Gastrointest Endosc 2017 ; 86 : 107-17.
PubMed
21) de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012 ; 18 : 1235-42.
 
22) Brown JB, et al. Goal-directed resuscitation in the prehospital setting : A propensity-adjusted analysis. J Trauma Acute Care Surg 2013 ; 74 : 1207-12.
PubMed
23) Neal MD, et al. Crystalloid to packed red blood cell transfusion ratio in massively transfused patient : When a little goes a long way. J Trauma Acute Care Surg 2012 ; 72 : 892-8.
 
24) Cantle PM, Cotton BA. Prediction of Massive Transfusion in Trauma. Crit Care Clin 2017 ; 33 : 71-84.
PubMed
25) Yucel N, et al. Trauma Associated Severe Hemorrhage (TASH) -Score : Probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006 ; 6 : 1228-36.
PubMed
26) Nunez TC, et al. Early prediction of massive transfusion in trauma : Simple as ABC (assessment of blood consumption)? J Trauma 2009 ; 66 : 346-52.
PubMed
27) Cotton BA, et al. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma 2010 ; 69 Suppl 1 : S33-9.
 
28) Morrison CA, et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock : Preliminary results of a randomized controlled trial. J Trauma 2011 ; 70 : 652-63.
PubMed
29) Schreiber MA, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients : Results of a prospective randomized pilot trial. J Trauma Acute Care Surg 2015 ; 78 : 687-95.
 
30) American Society of Anesthesiologists. Committee on Patient Blood Management. https://www.asahq.org/about-asa/governance-and-committees/asa-committees/committee-on-patient-blood-management
 
31) Rossaint R, et al. The European guideline on management of major bleeding and coagulopathy following trauma : Fourth edition. Crit Care 2016 ; 20 : 100.
PubMed
32) Brenner M, et al. Joint statement from the American College of Surgeons Committee on Trauma (ACS COT) and the American College of Emergency Physicians (ACEP) regarding the clinical use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). Trauma Surg Acute Care Open 2018 ; 3 : e000154.
PubMed
33) CRASH-2 trial collaborators, Shakur H, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) : A randomised, placebo-controlled trial. Lancet 2010 ; 376 : 23-32.
PubMed
34) CRASH-2 collaborators, Roberts I, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients : An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011 ; 377 : 1096-101, 1101.e1-2.
 
35) 日本産科婦人科学会, ほか. 産科危機的出血への対応指針 2017. http://www.fukushihoken.metro.tokyo.jp/iryo/k_isyoku/yuketsu-manual.files/29guideline.pdf
 
P.137 掲載の参考文献
1) Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016 ; 315 : 801-10.
PubMed
2) Nakahara M, et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One 2013 ; 8 : e75961.
PubMed
3) Zhang C, et al. High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) C (a 2+) leak through TLR4-ROS signaling in cardiomyocytes. J Mol Cell Cardiol 2014 ; 74 : 260-73.
 
4) Rhodes A, et al. Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Crit Care Med 2017 ; 45 : 486-552.
PubMed
5) 日本集中治療医学会・日本救急医学会合同 日本版敗血症診療ガイドライン2016作成特別委員会. 日本版敗血症診療ガイドライン 2016. http://www.jaam.jp/html/info/2017/pdf/J-SSCG2016_honpen.pdf
 
6) Perera P, et al. The RUSH exam : Rapid Ultrasound in Shock in the evaluation of the critically ill. Emerg Med Clin North Am 2010 ; 28 : 29-56.
 
7) Lichtenstein D. FALLS-protocol : lung ultrasound in hemodynamic assessment of shock. Heart Lung Vessel 2013 ; 5 : 142-7.
PubMed
8) Monnet X, Teboul JL. Passive leg raising : Five rules, not a drop of fluid! Crit Care 2015 ; 19 : 18.
PubMed
9) Yang X, Du B. Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care 2014 ; 18 : 650.
PubMed
10) Cannesson M, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness : A "gray zone" approach. Anesthesiology 2011 ; 115 : 231-41.
 
11) Theerawit P, et al. Inferior vena cava diameter variation compared with pulse pressure variation as predictors of fluid responsiveness in patients with sepsis. J Crit Care 2016 ; 36 : 246-51.
PubMed
12) Marik PE, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients : Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008 ; 36 : 1937-49.
PubMed
13) 厚生労働省医薬・生活衛生局. 血液製剤の使用指針. 平成29年3月. https://www.mhlw.go.jp/file/06-Seisakujouhou-11120000-Iyakushokuhinkyoku/0000161115.pdf
 
14) Vincent JL, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005 ; 23 : 400-5.
PubMed
15) Cruz DN, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial. JAMA 2009 ; 301 : 2445-52.
PubMed
16) Gotts JE, Matthay MA. Sepsis : Pathophysiology and clinical management. BMJ 2016 ; 353 : i1585.
PubMed
P.147 掲載の参考文献
1) Simons FE, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011 ; 4 : 13-37.
PubMed
2) 海老澤元宏. アナフィラキシーガイドライン-初期対応と再発予防の重要性. アレルギー 2015 ; 64 : 24-31.
Medical*Online
3) LoVerde D, et al. Anaphylaxis. Chest 2018 ; 153 : 528-43.
PubMed
4) Dewachter P, et al. Anaphylaxis and anesthesia : Controversies and new insights. Anesthesiology 2009 ; 111 : 1141-50.
PubMed
5) Simons FE. Anaphylaxis. J Allegy Clin Immunol 2010 ; 125 : S161-81.
 
6) Brown SG, et al. Insect sting anaphylaxis ; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004 ; 21 : 149-54.
PubMed
7) Grunau BE, et al. Emergency Department Corticosteroid Use for Allergy or Anaphylaxis Is Not Associated With Decreased Relapses. Ann Emerg Med 2015 ; 66 : 381-9.
PubMed
8) Wang ML, et al. Chlorhexidine-related refractory anaphylactic shock : A case successfully resuscitated with extracorporeal membrane oxygenation. J Clin Anesth 2016 ; 34 : 654-7.
PubMed
P.154 掲載の参考文献
1) Popa C, et al. Vascular dysfunctions following spinal cord injury. J Med Life 2010 ; 3 : 275-85.
PubMed
2) Taylor MP, et al. Presentation of neurogenic shock within the emergency department. Emerg Med J 2017 ; 34 : 157-62.
PubMed
3) Guly HR, et al. The incidence of neurogenic shock in patients with isolated spinal cord injury in the emergency department. Resuscitation 2008 ; 76 : 57-62.
PubMed
4) Harrigan MR, et al. Management of vertebral artery injuries following non-penetrating cervical trauma. Neurosurgery 2013 ; 72 Suppl 2 : 234-43.
 
5) Summers RL, et al. Characterization of the spectrum of hemodynamic profiles in trauma patients with acute neurogenic shock. J Crit Care 2013 ; 28 : 531.e1-5.
 
6) Astiz ME, et al. Pathophysiology and treatment of circulatory shock. Crit Care Clin 1993 ; 9 : 183-203.
PubMed
7) Walsh M, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery : Toward an empirical definition of hypotension. Anesthesiology 2013 ; 119 : 507-15.
PubMed
8) Joffe I. Circulatory shock. N Engl J Med 2014 ; 370 : 582-3.
PubMed
9) Ryken TC, et al. The acute cardiopulmonary management of patients with cervical spinal cord injuries. Neurosurgery 2013 ; 72 Suppl 2 : 84-92.
 
P.163 掲載の参考文献
1) 日本産科婦人科学会, 編. 産科婦人科用語集・用語解説集. 改訂第4版. 日本産科婦人科学会事務局 ; 2018. p.102.
 
2) 中堀泰賢, ほか. 全国救命救急センターにおける妊産婦入院症例に関する調査-救急部門と周産期部門との連携の現状と課題. 日救急医会誌 2011 ; 22 : 156-64.
 
3) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会. 母体安全への提言 2016 Vol.7. 2017 ; 1-68. http://www.jaog.or.jp/wp/wp-content/uploads/2017/08/botai_2016_2.pdf
 
4) 日本産科婦人科学会, ほか. 産科危機的出血への対応指針 2017. http://www.fukushihoken.metro.tokyo.jp/iryo/k_ishoku/yuketsu-manual.files/29guideline.pdf
 
5) Robertson JJ, et al. Emergency medicine myths : Ectopic pregnancy evaluation, risk factors, and presentation. J Emerg Med 2017 ; 53 : 819-28.
PubMed
6) Committee on Practice Bulletins-Obstetrics ; American College of Obstetricians and Gynecologists. ACOG Practice Bulletin Number 183, October 2017 : Postpartum hemorrhage. Obstet Gynecol 2017 ; 130 : e168-86.
 
7) Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006 ; 108 : 1005-16.
PubMed
8) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会. 母体安全への提言 2011 Vol.2. 2012 ; 1-47. http://www.jaog.or.jp/wp/wp-content/uploads/2017/01/botai_2011.pdf
 
9) Kanayama N, et al. Amniotic fluid embolism : Pathophysiology and new strategies for management. J Obstet Gynaecol Res 2014 ; 40 : 1507-17.
PubMed
10) 金山尚裕. 羊水塞栓症-DIC型後産期出血との関連について. 産科と婦人科 2009 ; 76 : 1091-6.
Medical*Online
11) Todo Y, et al. Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism : A case report. Clin Case Rep 2015 ; 3 : 673-75.
PubMed
12) Pacheco LD, et al. Amniotic fluid embolism : Diagnosis and management. Am J Obstet Gynecol 2016 ; 215 : B16-24.
PubMed
13) 真木正博, ほか. 産科DICスコア. 産婦人科治療 1985 ; 50 : 119-24.
 
14) Erez O. Disseminated intravascular coagulation in pregnancy-Clinical phenotypes and diagnostic scores. Thromb Res 2017 ; 151 : S56-60.
PubMed
P.173 掲載の参考文献
1) 赤水尚史, ほか, 日本甲状腺学会, 日本内分泌学会, 編. 甲状腺クリーゼの診断基準 (第2版). 甲状腺クリーゼ診療ガイドライン 2017. 東京 : 南江堂 ; 2017. http://www.japanthyroid.jp/doctor/img/thyroid_storm_or_crisis.pdf
 
2) Myers L, Hays J. Myxedema coma. Crit Care Clin 1991 ; 7 : 43-56.
PubMed
3) 田中祐司, ほか, 日本甲状腺学会. 粘液水腫性昏睡の診断基準と治療指針の作成委員会. 粘液水腫性昏睡の診断基準 (3次案). 2010. http://www.japanthyroid.jp/doctor/img/shindan.pdf
 
4) 小西美絵乃, ほか. 難治性甲状腺疾患 粘液水腫性昏睡. 日内会誌 2010 ; 99 : 769-75.
 
5) Puar TH, et al. Adrenal crisis : Still a deadly event in the 21st century. Am J Med 2016 ; 129 : 339.e1-9.
 
6) 柳瀬敏彦, ほか. 副腎クリーゼを含む副腎皮質機能低下症の診断と治療に関する指針. 日内分泌会誌 2015 ; 91 Suppl September : 1-78.
 
7) Taylor RL, et al. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem 2004 ; 50 : 2345-52.
PubMed
8) Hahner S, et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency : A prospective study. J Clin Endocrinol Metab 2015 ; 100 : 407-16.
PubMed
9) 眞田淳平, ほか. 高血糖緊急症. 日内会誌 2016 ; 105 : 690-7.
 
10) Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician 2005 ; 71 : 1723-30.
PubMed
P.184 掲載の参考文献
1) Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979 ; 59 : 607-9.
PubMed
2) Yahagi K, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol 2016 ; 13 : 79-98.
PubMed
3) Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation 2018 ; 138 : e618-51.
PubMed
4) Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018 ; 39 : 119-77.
 
5) O'Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 ; 61 : e78-140.
 
6) Hochman JS, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006 ; 355 : 2395-407.
PubMed
7) Roffi M, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016 ; 37 : 267-315.
 
8) Serruys PW, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009 ; 360 : 961-72.
PubMed
9) Mohr FW, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease : 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013 ; 381 : 629-38.
PubMed
10) Amsterdam EA, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 ; 64 : e139-228.
 
11) Swan HJ, et al. Hemodynamic Spectrum of Myocardial Infarction and Cardiogenic Shock. A conceptual model. Circulation 1972 ; 45 : 1097-110.
PubMed
12) Kohsaka S, et al. Systemic Inflammatory Response Syndrome After Acute Myocardial Infarction Complicated by Cardiogenic Shock. Arch Intern Med 2005 ; 165 : 1643-50.
PubMed
13) Figueras J, et al. Left ventricular free wall rupture : Clinical presentation and management. Heart 2000 ; 83 : 499-504.
PubMed
14) Honda S, et al. Trends in the Clinical and Pathological Characteristics of Cardiac Rupture in Patients With Acute Myocardial Infarction Over 35 Years. J Am Heart Assoc 2014 ; 3 : e000984.
PubMed
15) Binanay C, et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness : The ESCAPE Trial. JAMA 2005 ; 294 : 1625-33.
PubMed
16) Birnbaum Y, et al. Ventricular Septal Rupture after Acute Myocardial Infarction. N Engl J Med 2002 ; 347 : 1426-32.
PubMed
17) Lopez-Sendon J, et al. Sensitivity and Specificity of Hemodynamic Criteria in the Diagnosis of Acute Right Ventricular Infarction. Circulation 1981 ; 64 : 515-25.
PubMed
P.192 掲載の参考文献
1) Mant J, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009 ; 13 : 1-207.
PubMed
2) Connors AF Jr, et al ; SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996 ; 276 : 889-97.
 
3) Sotomi Y, et al. Impact of pulmonary artery catheter on outcome in patients with acute heart failure syndromes with hypotension or receiving inotropes : From the ATTEND Registry. Int J Cardiol 2014 ; 172 : 165-72.
PubMed
4) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 ; 362 : 779-89.
 
5) 水野友裕. IABP. 関口敦. 最新にして上々! 補助循環マニュアル. 大阪 : メディカ出版 ; 2015. p.33.
 
6) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). p.98. http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf
 
P.201 掲載の参考文献
1) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
 
2) Link MS, et al. Part 7 : Adult Advanced Cardiovascular Life Support : 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015 ; 132 (18 Suppl 2) : S444-64.
 
3) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
 
4) Pedersen CT, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm 2014 ; 11 : e166-96.
PubMed
5) Kudenchuk PJ, et al ; Resuscitation Outcomes Consortium Investigators. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. N Engl J Med 2016 ; 374 : 1711-22.
 
6) Bourke T, et al. Neuraxial modulation for refractory ventricular arrhythmias : Value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010 ; 121 : 2255-62.
PubMed
7) Do DH, et al. Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc 2017 ; 6. pii : e007080. doi : 10.1161/JAHA.117.007080.
 
8) Reddy VY, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007 ; 357 : 2657-65.
PubMed
9) Sapp JL, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016 ; 375 : 111-21.
PubMed
P.206 掲載の参考文献
1) Fiedler A. Ueber akute interstitielle Myokarditis. In : Festschrift zur Feier des funfzigjahrigen Bestehens des Stadtkrankenhauses zu Dresden-Friedrichstadt. part 2. Dresden : Wilhelm Baensch ; 1899. p3.
 
2) McCarthy RE 3rd, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000 ; 342 : 690-5.
PubMed
3) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 急性および慢性心筋炎の診断・治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_izumi_h.pdf
 
4) Hiramitsu S, et al. Significance of transient left ventricular wall thickening in acute lymphocytic myocarditis. Heart Vessels 2007 ; 22 : 25-9.
PubMed
5) Naruke T, et al. End-tidal carbon dioxide concentration can estimate the appropriate timing for weaning off from extracorporeal membrane oxygenation for refractory circulatory failure. Int Heart J 2010 ; 51 : 116-20.
PubMed
6) Cooper LT Jr, et al. Idiopathic giant-cell myocarditis. Natural history and treatment. N Engl J Med 1997 ; 336 : 1860-6.
PubMed
7) Kato S, et al. Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 2007 ; 22 : 48-51.
PubMed
8) Mason JW, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995 ; 333 : 269-75.
 
P.214 掲載の参考文献
1) Akashi YJ, et al. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol 2015 ; 12 : 387-97.
PubMed
2) Lyon AR, et al. Current state of knowledge on Takotsubo syndrome : A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2016 ; 18 : 8-27.
 
3) Ghadri JR, et al. International Expert Consensus Document on Takotsubo Syndrome-PART I : Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J 2018 ; 39 : 2032-46.
PubMed
4) Akashi YJ, et al. Takotsubo cardiomyopathy : A new form of acute, reversible heart failure. Circulation 2008 ; 118 : 2754-62.
PubMed
5) Deshmukh A, et al. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 2012 ; 164 : 66-71. e1.
 
6) Ghadri JR, et al. Happy heart syndrome : Role of positive emotional stress in takotsubo syndrome. Eur Heart J 2016 ; 37 : 2823-9.
PubMed
7) Wittstein IS, et al. Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress. N Engl J Med 2005 ; 352 : 539-48.
PubMed
8) Frustaci A, et al. Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study. Chest 1991 ; 99 : 382-5.
PubMed
9) Templin C, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015 ; 373 : 929-38.
PubMed
10) Randhawa MS, et al. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail 2014 ; 20 : 377. e25-31.
 
11) Akashi YJ, et al. Reversible ventricular dysfunction takotsubo cardiomyopathy. Eur J Heart Fail 2005 ; 7 : 1171-6.
PubMed
12) Morel O, et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 2009 ; 15 : 206-13.
 
13) Kosuge M, et al. Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 2010 ; 55 : 2514-6.
PubMed
14) Kosuge M, et al. Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. Circ J 2012 ; 76 : 462-8.
PubMed
15) Pathik B, et al. Troponin-positive chest pain with unobstructed coronary arteries : Incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2016 ; 17 : 1146-52.
PubMed
16) Hasbak P, et al. Preserved myocardial blood flow in the apical region involved in takotsubo cardiomyopathy by quantitative cardiac PET assessment. J Nucl Cardiol 2012 ; 19 : 169-71.
 
17) Akashi YJ, et al. 123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy. J Nucl Med 2004 ; 45 : 1121-7.
PubMed
18) Burgdorf C, et al. Regional alterations in myocardial sympathetic innervation in patients with transient left-ventricular apical ballooning (Tako-Tsubo cardiomyopathy). J Nucl Cardiol 2008 ; 15 : 65-72.
PubMed
19) Christensen TE, et al. (123) I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. JACC Cardiovasc Imaging 2016 ; 9 : 982-90.
PubMed
20) Palla AR, et al. Pretreatment With Low-Dose beta-Adrenergic Antagonist Therapy Does Not Affect Severity of Takotsubo Cardiomyopathy. Clin Cardiol 2012 ; 35 : 478-81.
PubMed
21) Isogai T, et al. Early beta-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy. Heart 2016 ; 102 : 1029-35.
PubMed
22) Kagiyama N, et al. Impact of right ventricular involvement on the prognosis of takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016 ; 17 : 210-6.
PubMed
23) Singh K, et al. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol 2014 ; 174 : 696-701.
PubMed
24) Brunetti ND, et al. Combined therapy with beta-blockers and ACE-inhibitors/angiotensin receptor blockers and recurrence of Takotsubo (stress) cardiomyopathy : A meta-regression study. Int J Cardiol 2017 ; 230 : 281-3.
PubMed
25) Isogai T, et al. Out-of-hospital versus in-hospital Takotsubo cardiomyopathy : Analysis of 3719 patients in the Diagnosis Procedure Combination database in Japan. Int J Cardiol 2014 ; 176 : 413-7.
PubMed
26) Stiermaier T, et al. Prognostic Usefulness of the Ballooning Pattern in Patients With Takotsubo Cardiomyopathy. Am J Cardiol 2016 ; 118 : 1737-41.
PubMed

4章 治療選択

P.227 掲載の参考文献
1) Huang CC, et al. Prediction of fluid responsiveness in acute respiratory distress syndrome patients ventilated with low tidal volume and high positive end-expiratory pressure. Crit Care Med 2008 ; 36 : 2810-6.
PubMed
2) van den Berg PC, et al. Effect of positive pressure on venous return in volume-loaded cardiac surgical patients. J Appl Physiol 2002 ; 92 : 1223-31.
PubMed
3) Romand JA, et al. Cardiopulmonary effects of positive pressure ventilation during acute lung injury. Chest 1995 ; 108 : 1041-8.
PubMed
4) Ivatury RR, et al. Intra-abdominal hypertension after life-threatening penetrating abdominal trauma : Prophylaxis, incidence, and clinical relevance to gastric mucosal pH and abdominal compartment syndrome. J Trauma 1998 ; 44 : 1016-21.
PubMed
5) Peter JV, et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema : A meta-analysis. Lancet 2006 ; 367 : 1155-63.
PubMed
6) Mehta S, et al. Noninvasive ventilation in patients with acute cardiogenic pulmonary edema. Respir Care 2009 ; 54 : 186-95.
PubMed
7) Rochwerg B, et al. Official ERS/ATS clinical practice guidelines : Noninvasive ventilation for acute respiratory failure. Eur Respir J 2017 ; 50 : pii : 1602426.
 
8) Frat JP, et al ; FLORALI Study Group ; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015 ; 372 : 2185-96.
 
9) Parke R, et al. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth 2009 ; 103 : 886-90.
PubMed
10) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.asas.or.jp/jhfs/pdf/topics20180323.pdf
 
11) Amato MB, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015 ; 372 : 747-55.
PubMed
12) Serpa Neto A, et al ; PROVE Network Investigators. Protective versus Conventional Ventilation for Surgery : A Systematic Review and Individual Patient Data Meta-analysis. Anesthesiology 2015 ; 123 : 66-78.
PubMed
13) Liu J, et al. Cardiac dysfunction induced by weaning from mechanical ventilation : Incidence, risk factors, and effects of fluid removal. Crit Care 2016 ; 20 : 369.
PubMed
14) Chien JY, et al. Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit Care Med 2008 ; 36 : 1421-6.
 
P.237 掲載の参考文献
1) 村田寛明, ほか. 循環薬理. 澄川耕二, 編. 周術期循環管理. 東京 : 克誠堂出版 ; 2011. p.225-33.
 
2) Dellinger RP, et al ; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign : International guidelines for management of severe sepsis and septic shock : 2012. Crit Care Med 2013 ; 41 : 580-637.
PubMed
3) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 東京 : 東京医学社 ; 2016. p.49-51.
 
4) Martin C, et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990 ; 18 : 282-5.
PubMed
5) Redl-Wenzl EM, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993 ; 19 : 151-4.
 
6) Iribe G, et al. Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism. Crit Care Med 2000 ; 28 : 743-8.
PubMed
P.247 掲載の参考文献
1) 大野博司. ICU/CCUの薬の考え方, 使い方 ver.2. 東京 : 中外医学社 ; 2016. p.109-17.
 
2) Imm A, Carlson RW. Fluid resuscitation in circulatory shock. Crit Care Clin 1993 ; 9 : 313-33.
PubMed
3) Raghunathan K, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014 ; 42 : 1585-91.
PubMed
4) Semler MW, et al. Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial. Am J Respir Crit Care Med 2017 ; 195 : 1362-72.
PubMed
5) Semler MW, et al. Balanced Crystalloids versus Saline in Critically ill Adults. N Engl J Med 2018 ; 378 : 829-39.
PubMed
6) Self WH, et al. Balanced Crystalloids versus Saline in Noncritically ill Adults. N Engl J Med 2018 ; 378 : 819-28.
PubMed
7) Brunkhorst FM, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 ; 358 : 125-39.
PubMed
8) Perner A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012 ; 367 : 124-34.
 
9) Myburgh JA, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012 ; 367 : 1901-11.
 
10) Annane D, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock. The CRISTAL randomized trial. JAMA 2013 ; 310 : 1809-17.
PubMed
11) Finfer S, et al. A comparison of albumin and saline for fluid resusicitation in the intensive care unit. The SAFE study investigators. N Engl J Med 2004 ; 350 : 2247-56.
 
12) Delaney AP, et al. The role of albumin as a resuscitation fluid for patients with sepsis : A systematic review and meta-analysis. Crit Care Med 2011 ; 39 : 386-91.
PubMed
13) Caironi P, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014 ; 370 : 1412-21.
 
14) Rhodes A, et al. Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Crit Care Med 2017 ; 45 : 486-552.
PubMed
15) Karvellas CJ, Subramanian RM. Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure. Crit Care Clin 2016 ; 32 : 439-51.
PubMed
16) Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010 ; 87 : 198-210.
PubMed
17) Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013 ; 369 : 1243-51.
PubMed
18) Li Y, et al. The kinetics of Ringer's solution in young and elderly patients during induction of general anesthesia with propofol and epidural anesthesia with ropivacaine. Acta Anaesthesiol Scand 2007 ; 51 : 880-7.
 
19) Chappell D, et al. A rational approach to perioperative fluid management. Anesthesiology 2008 ; 109 : 723-40.
 
20) Maitland K, et al. Mortality after Fluid Bolus in African Children with Severe Infection. N Engl J Med 2011 ; 364 : 2483-95.
PubMed
21) Marik PE, Lemson J. Fluid responsiveness : An evolution of our understanding. Br J Anaesth 2014 ; 112 : 617-20.
PubMed
22) Osman D, et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007 ; 35 : 64-8.
 
23) Yang X, Du B. Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care 2014 ; 18 : 650.
PubMed
24) Soubrier S, et al. Can dynamic indicators help the prediction of fluid responsiveness in spontaneously brething critically ill patients? Intensive Care Med 2007 ; 33 : 1117-24.
PubMed
25) Durairaj L, et al. Fluid therapy in resuscitated sepsis : Less is more. Chest 2008 ; 133 : 252-63.
PubMed
26) De Backer D, et al. Pulse pressure variations to predict fluid responsivenesss : Influence of tidal volume. Intensive Care Med 2005 ; 31 : 517-23.
 
27) De Backer D, et al. Influence of respiratory rate on stroke volume variation in mechanically ventilated patients. Anesthesiology 2009 ; 110 : 1092-7.
PubMed
28) Monnet X, et al. Passive leg-raising and end-expiratory occlusion tests perform better than pulse pressure variation in patients with low respiratory system complication. Crit Care Med 2012 ; 40 : 152-7.
 
29) Wyler von Ballmoos M, et al. Pulse-pressure variation and hemodynamic response in patients with elevated pulmonary artery pressure : A clinical study. Crit Care 2010 ; 14 : R111.
PubMed
30) 増山智之, 讃井將満. 輸液必要性と輸液反応性─その考え方と指標について. Intensivist 2017 ; 9 : 311-26.
 
31) Monnet X, Teboul JL. Passive leg raising : Five rules, not a drop of fluid! Crit Care 2015 ; 19 : 18.
PubMed
P.255 掲載の参考文献
1) Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Continuing Education in Anaesthesia, Critical Care & Pain 2009 ; 9 : 24-8.
 
2) Thiele H, et al ; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 ; 367 : 1287-96.
PubMed
3) Stevenson LW, et al. INTERMACS profiles of advanced heart failure : The current picture. J Heart Lung Transplant 2009 ; 28 : 535-41.
PubMed
4) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.asas.or.jp/jhfs/pdf/topics20180323.pdf
 
5) Pucher PH, et al. Is heparin needed for patients with an intra-aortic balloon pump? Interact Cardiovasc Thorac Surg 2012 ; 15 : 136-9.
PubMed
P.265 掲載の参考文献
1) Annich GM, et al, eds. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 4th ed. "Red Book". ELSO ; 2012.
 
2) Huang CT, et al. Extracorporeal membrane oxygenation resuscitation in adult patients with refractory septic shock. J Thorac Cardiovasc Surg 2013 ; 146 : 1041-6.
PubMed
3) MacLaren G, et al. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011 ; 12 : 133-6.
PubMed
4) Ko WJ, et al. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002 ; 73 : 538-45.
PubMed
5) Maclaren G, Butt W. Extracorporeal membrane oxygenation and sepsis. Crit Care Resusc 2007 ; 9 : 76-80.
PubMed
6) Brechot N, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med 2013 ; 41 : 1616-26.
PubMed
7) Extracorporeal Life Support Organization. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Version 1.3. Ann Arbor, MI, USA ; November 2013. https://www.elsonet.org
 
8) Gass A, et al. Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology 2014 ; 129 : 137-43.
PubMed
9) Takayama H, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013 ; 32 : 106-11.
PubMed
10) Petroni T, et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation*. Crit Care Med 2014 ; 42 : 2075-82.
PubMed
11) Ma P, et al. Combining ECMO with IABP for the treatment of critically Ill adult heart failure patients. Heart Lung Circ 2014 ; 23 : 363-8.
PubMed
12) Cheng R, et al. Lack of Survival Benefit Found With Use of Intraaortic Balloon Pump in Extracorporeal Membrane Oxygenation : A Pooled Experience of 1517 Patients. J Invasive Cardiol 2015 ; 27 : 453-8.
PubMed
Extracorporeal Life Support Organization (ELSO). Guidelines for Adult Cardiac Failure. https://www.elso.org/Portals/0/IGD/Archive/FileManager/e76ef78eabcusersshyerdocumentselsoguidelinesforadultcardiacfailure1.3.pdf
 
Extracorporeal Life Support Organization (ELSO). Ultrasound Guidance for Extra-corporeal Membrane Oxygenation Veno-Arterial ECMO specific guidelines. https://www.elso.org/Portals/0/Files/elso_Ultrasoundguidance_vvecmo_guidelines_MAY2015.pdf
 
P.274 掲載の参考文献
1) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf
 
2) Imamura T, et al. High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement. J Artif Organs 2016 ; 19 : 44-53.
 
3) Kimura M, et al. Successful Treatment of Intractable Fluid Retention Using Tolvaptan After Treatment for Postoperative Mediastinitis in a Patient With a Left Ventricular Assist Device. Int Heart J 2015 ; 56 : 574-7.
 
4) Imamura T, et al. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device. J Artif Organs 2013 ; 16 : 101-4.
 
5) Imamura T, et al. Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. J Artif Organs 2014 ; 17 : 23-32.
 
P.280 掲載の参考文献
1) Behar S, et al ; SPRINT Study Group. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. Am J Cardiol 1993 ; 72 : 831-4.
 
2) Kimura K, et al. Comparison of results of early reperfusion in patients with inferior wall acute myocardial infarction with and without complete atrioventricular block. Am J Cardiol 1999 ; 84 : 731-3.
PubMed
3) Bryd CL. Clinical experience with the extrathoracic introducer insertion technique. Pacing Clin Electrophysiol 1993 ; 16 : 1781-4.
 
4) Magney JE, et al. A new approach to percutaneous subclavian venipuncture to avoid lead fracture or central venous catheter occlusion. Pacing Clin Electrophysiol 1993 ; 16 : 2133-42.
PubMed
5) Cha EM, Khoury GH. Persistent left superior vena cava. Radiologic and clinical significance. Radiology 1972 ; 103 : 375-81.
PubMed
P.287 掲載の参考文献
1) 日本循環器学会 (班長 : 相澤義房), ほか. 循環器病の診断と治療に関するガイドライン (2003-2004年度合同研究班報告). 心臓突然死の予知と予防法のガイドライン. Circ J 2005 ; 69 Suppl IV : 1253.
 
2) Myerburg RJ, et al. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992 ; 85 Suppl 1 : I2-10.
 
3) AVID investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997 ; 337 : 1576-83.
 
4) Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013 ; 127 : e283-352.
 
5) Moss AJ, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 ; 335 : 1933-40.
 
6) Moss AJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 ; 346 : 877-83.
PubMed
7) Buxton AE, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 ; 341 : 1882-90.
 
8) Bardy GH, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 ; 352 : 225-37.
 
9) Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013 ; 127 : e283-352.
 
10) 日本循環器学会 (班長 : 奥村謙), ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2011年改訂版). www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
 
11) Solomon SD, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005 ; 352 : 2581-8.
 
12) Hohnloser SH, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 ; 351 : 2481-8.
PubMed
13) Steinbeck G, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009 ; 361 : 1427-36.
PubMed
14) Pedersen CT, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm 2014 ; 11 : e166-96.
PubMed
15) Klein HU, et al. Risk stratification for implantable cardioverter defibrillator therapy : The role of the wearable cardioverter-defibrillator. Eur Heart J 2013 ; 34 : 2230-42.
PubMed
16) 日本不整脈心電学会WCDワーキンググループ (庭野慎一, ほか). 着用型自動除細動器 (WCD) の臨床使用に関するステートメント (2018年2月改訂). http://new.jhrs.or.jp/pdf/guideline/statement20180215.pdf
 
17) Kutyifa V, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients : Data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation 2015 ; 132 : 1613-9.
PubMed
18) Moss AJ, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012 ; 367 : 2275-83.
PubMed
19) Sasaki S, et al. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circ J 2014 ; 78 : 2987-9.
PubMed
20) Kishihara J, et al. An appropriate shock of the wearable cardioverter-defibrillator in outpatient setting. J Arrhythmia 2016 ; 32 : 67-9.
 
21) Niwano S, et al. Clinical Usefulness of Wearable Cardioverter Defibrillator (WCD) and Current Understanding of Its Clinical Indication in Japan. Circ J 2018 ; 82 : 1481-6.
PubMed
P.295 掲載の参考文献
1) Corwin HL, et al. The CRIT Study : Anemia and blood transfusion in the critically ill--Current clinical practice in the United States. Crit Care Med 2004 ; 32 : 39-52.
PubMed
2) Hebert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999 ; 340 : 409-17.
 
3) Holst LB, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014 ; 371 : 1381-91.
PubMed
4) Carson JL, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011 ; 365 : 2453-62.
 
5) Murphy GJ, et al ; TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015 ; 372 : 997-1008.
 
6) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 : 1368-77.
PubMed
7) ARISE Investigators ; ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014 ; 371 : 1496-506.
 
8) Mazer CD, et al. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery. N Engl J Med 2017 ; 377 : 2133-44.
 
9) Holcomb JB, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study : Comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013 ; 148 : 127-36.
PubMed
10) Holcomb JB, et al ; for the PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1 : 1 : 1 vs a 1 : 1 : 2 ratio and mortality in patients with severe trauma : the PROPPR randomized clinical trial. JAMA 2015 ; 313 : 471-82.
 
P.301 掲載の参考文献
1) Ellison DH, Felker GM. Diuretic Treatment in Heart Failure. N Engl J Med 2017 ; 377 : 1964-75.
PubMed
2) Mitaka C, et al. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients : A systematic review and meta-analysis. Crit Care 2011 ; 15 : R258.
PubMed
3) Russell JA, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008 ; 358 : 877-87.
PubMed
4) Russell JA, et al. The Septic Shock 3.0 Definition and Trials : A Vasopressin and Septic Shock Trial Experience. Crit Care Med 2017 ; 45 : 940-8.
 
P.310 掲載の参考文献
1) 日本循環器学会, ほか. 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf
 
2) Basuray A, et al. Heart failure with recovered ejection fraction : Clinical description, biomarkers, and outcomes. Circulation 2014 ; 129 : 2380-7.
PubMed
3) Nijst P, et al. Heart Failure with Myocardial Recovery-The Patient Whose Heart Failure Has Improved : What Next? Prog Cardiovasc Dis 2017 ; 60 : 226-36.
PubMed
4) 奥村貴裕. 投与中の心筋保護薬. やめたらどうなるの? 循環器ジャーナル 2018 ; 66 : 30-8.
 
5) Ishihara S, et al. Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome. Circ J 2012 ; 76 : 1169-76.
PubMed
6) Kotecha D, et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation : An individual-patient data meta-analysis. Lancet 2014 ; 384 : 2235-43.
 
7) Valluri A, et al. Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure. Curr Heart Fail Rep 2014 ; 11 : 31-9.
PubMed
8) Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016 ; 37 : 2129-200.
 
9) Fonarow GC, et al. Heart failure care in the outpatient cardiology practice setting : Findings from IMPROVE HF. Circ Heart Fail 2008 ; 1 : 98-106.
 
10) Fonarow GC, et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure : Findings from the OPTIMIZE-HF program. J Am Coll Cardiol 2008 ; 52 : 190-9.
PubMed
11) 奥村貴裕. 急性心不全治療におけるPDE III阻害薬の使い方. 循環器ジャーナル 2017 ; 65 : 100-7.
 
12) Kane JA, et al. Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction. Cardiology 2017 137 : 121-5.
PubMed
P.317 掲載の参考文献
1) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 非ST上昇型急性冠症候群の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_kimura_h.pdf
 
2) Wiviott SD, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007 ; 357 : 2001-15.
PubMed
3) Wallentin L, et al ; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009 ; 361 : 1045-57.
PubMed
4) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). ST上昇型急性心筋梗塞の診療に関するガイドライン (2013年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_kimura_h.pdf
 
5) Kushner FG, et al. 2009 Focused Updates : ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update) : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009 ; 120 : 2271-306.
 
6) 日本循環器学会, ほか. 2016-2017年度活動. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_ito_h.pdf
 
7) Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism : A controlled trial. Lancet 1960 ; 1 : 1309-12.
PubMed
8) Konstantinides SV, et al ; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014 ; 35 : 3033-69.
 
9) Zarychanski R, et al. The efficacy and safety of heparin in patients with sepsis : A systematic review and metaanalysis. Crit Care Med 2015 ; 43 : 511-8.
PubMed
10) Umemura Y, et al. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis : A meta-analysis of randomized controlled trials. J Thromb Haemost 2016 ; 14 : 518-30.
PubMed
11) Pollack CV Jr, et al. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med 2017 ; 377 : 431-41.
PubMed
12) Siegal DM, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015 ; 373 : 2413-24.
PubMed
13) Raimondi P, et al. Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events : Current Strategies. Curr Pharm Des 2017 ; 23 : 1406-23.
PubMed
P.325 掲載の参考文献
1) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
 
2) 池田隆徳. 薬剤編-抗不整脈薬. 池田隆徳, 編. これで決まり! 循環器治療薬ベストチョイス-こんな病態・症例にこの処方. 東京 : メジカルビュー社 ; 2012. p.55-60.
 
3) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
 
4) 日本循環器学会, ほか. 循環器病の診断と治療に関するガイドライン (2010-2011年度合同研究班報告). カテーテルアブレーションの適応と手技に関するガイドライン. http://www.j-circ.or.jp/guideline/pdf/JCS2012_okumura_h.pdf
 
P.333 掲載の参考文献
1) Dellinger RP, et al. Surviving Sepsis Campaign : International guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med 2008 ; 36 : 296-327.
PubMed
2) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 : 1368-77.
PubMed
3) Bone RC, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987 ; 317 : 653-8.
PubMed
4) Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976 ; 184 : 333-41.
PubMed
5) Annane D, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults : A systematic review. JAMA 2009 ; 301 : 2362-75.
PubMed
6) Annane D, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002 ; 288 : 862-71.
PubMed
7) Sprung CL, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008 ; 358 : 111-24.
PubMed
8) Nishida O, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg 2018 ; 5 : 3-89.
PubMed
9) Nishida O, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). J Intensive Care 2018 ; 6 : 7.
PubMed
10) Rhodes A, et al. Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Crit Care Med 2017 ; 45 : 486-552.
PubMed
11) Venkatesh B, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med 2018 ; 378 : 797-808.
PubMed
12) Annane D, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 2018 ; 378 : 809-18.
PubMed
13) Minneci PC, et al. The effects of steroids during sepsis depend on dose and severity of illness : An updated meta-analysis. Clin Microbiol Infect 2009 ; 15 : 308-18.
PubMed

書評

最近チェックした商品履歴

Loading...